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Abstract
Background: Paracoccidioidomycosis (PCM) is a neglected systemic mycosis caused by a dimorphic fungus of the
Paracoccidioides genus. The standard diagnosis is based on isolation of the fungi in culture, and by microscopic
visualization of characteristic multiple budding yeast cells in biological samples. However, in some situations, access
to the site of injury prevents the collection of biological material. A variety of immuno-serological techniques has
proven useful for allowing inferring diagnosis with a certain degree of certainty, thus optimizing time. The aim of
this study was to standardize and validate the Dot-ELISA (DE) assay, comparing it with the serological standard,
double immunodiffusion (DI).
Methods: In order to standardize the DE assay, 143 serum samples were used. Out of those, 23 were from
apparently healthy patients, 77 were from patients with confirmed PCM and 43 were from patients with other lung
infections (tuberculosis, aspergillosis and histoplasmosis). To validate the DE technique, 300 serum samples from
patients with PCM clinical suspicion (probable and possible cases) were employed, and these results were
compared with those of DI.
Results: The DE assay showed sensitivity of 91%, specificity of 95.4%, positive predictive value of 96%, negative
predictive value of 98.2%, accuracy of 93%, and great precision (k = 0.93). In addition, the nitrocellulose membranes
have proved to be viable for using at least 90 days after P. brasiliensis B-339 antigen sensitization.
Conclusion: Dot-ELISA method was found to be an extremely promising tool as serologic screening technique,
because of its high sensitivity. Furthermore, Dot-ELISA shows the prospect of being transferred to laboratories of
mycoserology including those with fewer resources or even to be used directly in the field. It has an excellent shelf
life – membranes coated with antigen can be used for testing without changes in the pattern of reactivity among
laboratories – and presents reliable values of sensitivity, specificity, predictive values, accuracy and a high correlation
with the serological standard methodology. Based on the present findings, it possible to state that this technique
constitutes a remarkable option to be used in routine diagnosis for public health centers.
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Background
Paracoccidioidomycosis (PCM) is the most important
systemic mycosis of Latin America caused by the ther-
mally dimorphic fungus Paracoccidioides spp. [1–4]. En-
demic areas extends from Argentina to Central America;
however, approximately 80% of PCM cases, especially
due to Paracoccidioides brasiliensis, have been reported
in Brazil [1, 5]. In Brazil, the disease is considered the
eighth cause of death among infectious and parasitic
diseases, presenting a mortality rate of 1.4 per million
inhabitants [6]. PCM presents a wide spectrum of clin-
ical manifestations and it is more frequent in males than
in females (a ratio of approximately 7.2:1) and affects
people from 30 to 60 years old, mainly the ones living in
rural areas [7–9].
The definitive diagnosis of P. brasiliensis infection
consists in the direct microscopic examination of bio-
logical specimens and their culturing followed by macro
and microscopic observation for the fungus identifica-
tion [10, 11]. However, serological techniques are usually
simpler than culture and are employed in early diagnosis
of PCM, they are also useful for monitoring its evolution
and response to treatment [3, 10–14].
Among different serological assays, double immuno-
diffusion (DI) is the standard method used for the diag-
nosis of PCM. DI assay is high specific, but its sensitivity
may vary between 65 to 100% depending on the anti-
genic preparation used [3, 12, 15]. Although the DI assay
has advantages regarding cost and feasibility, the imple-
mentation of a faster and more sensitive test in the sero-
logical routine method is necessary. It could contribute
to early initiation of appropriate therapy, which could
prevent further damage and help in monitoring fungal
dissemination to other organs.
In the past decades, many investigators have described
the application of serological tests to the diagnosis of
PCM. From the complement fixation test to the immu-
noenzymatic assays, there has been an increased interest
in methodologies that are fast, simple to perform and
inexpensive [3, 10, 12]. Dot-ELISA has been widely
accepted as a rapid, versatile and simple test based on
the principle of enzyme immunoassays, for the detection
of many protozoan, virus and fungus diseases [16]. The
use of Dot-ELISA for diagnosis of PCM was previously
reported by three groups – namely Taborda and
Camargo [17], Martins et al. [18] and Correa et al. [19]
– without crucial differences in sensitivity and specifi-
city. In all these tests, different reagents and antigenic
non-standardized preparations were employed.
In order to improve the serological parameters for the
diagnosis of PCM, the present study aimed to produce a
fast and accurate method to detect anti-P. brasiliensis
antibodies employing crude antigen (culture filtrate) and
to evaluate the performance and applicability of Dot-
ELISA assay as a rapid screening test for the diagnosis of




A study was designed with a total of 443 serum samples
obtained from March 2012 to June 2014 at the Labora-
tory of Mycosis Immunodiagnosis of Adolfo Lutz Insti-
tute and Department of Tropical Diseases of Botucatu
Medical School, UNESP. Seventy-seven serum samples
were from patients previously diagnosed with PCM
(proven cases), by finding the etiologic agent in bio-
logical samples. Twenty-three serum samples from
healthy individuals (normal human serum – NHS), sera
from individuals with tuberculosis (n = 20) and sera with
DI test confirming histoplasmosis (n = 16) and aspergil-
losis (n = 8) were used as controls (non-PCM). Three
hundred serum samples obtained from patients with
“clinical suspicion” (probable and possible cases) of
PCM were included in this study. The cases were classi-
fied following the Guideline on Paracoccidioidomycosis
[20] and EORTC/MSG Consensus Group criteria (Euro-
pean Organization for Research and Treatment of Can-
cer/Mycosis Study Group) [21]. All samples were
obtained from patients residing and domiciled in São
Paulo state. Proven cases were from Botucatu region,
probable and possible cases were from Campinas, Rio
Claro, Sorocaba and São Paulo regions. Anti-P. brasilien-
sis polyclonal antibody, obtained in rabbits, was
employed as positive control.
Ethics consideration
This study was approved by the Research Ethics Com-
mittee of Adolfo Lutz Institute, accession number
13673313.1.0000.0059.
P. brasiliensis antigen
The antigen used in this study was 20-day culture filtrate,
obtained according to Silva et al. [22], from the yeast
phase of B-339 P. brasiliensis (ATCC 32069TM) and Pb
113 strains. The fungi were cultured in NGTA – 3% (w/v)
neopeptone, 1.8% (w/v) glucose, 0.009% (w/v) asparagine,
and 0.125% (w/v) thiamine liquid medium for 20 days at
36 °C with shaking (50 rpm). After incubation time,
cultures were treated with an aqueous borate-thimerosal
solution (1:5,000), and left to stand for 96 h at 4 °C. After,
supernatants were filtered through Whatman n. 1 paper,
divided into small volumes and stored at 4 °C until use.
Protein contents were subsequently assessed by the Brad-
ford’s method [23].
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Dot-ELISA assay
The methodology was standardized according to the
protocols described by Hawkes et al. [24] and Pappas
[16] with some modifications. Dot-Elisa for detection of
P. brasiliensis was performed on nitrocellulose mem-
brane (NC) with 0.22 μm pores (Bio-Rad Laboratories,
USA) cut as 1x1 cm squares. The absorption of the P.
brasiliensis antigens to NC was performed by applying
6 μL of each antigenic preparation in each square,
followed by incubation for 30 minutes at 37 °C. After
drying, the free binding sites were blocked by 1 h incu-
bation in PBS (pH7.4) containing 5% non-fat dry milk
(PBS-L 5%), under continuous shaking at room
temperature. These adsorbed and blocked membranes
were stored at 8 °C, –20 °C and room temperature until
use.
For antibody detection, membranes were placed on
24-well plate and then incubated for 2 h with 500 μL of
individual sera from patients with PCM, tuberculosis,
histoplasmosis, aspergilosis and sera from healthy indi-
viduals diluted either 1:20, 1:40 or 1:100 in PBS contain-
ing 3% non-fat dry milk (PBS-L 3%), under continuous
shaking at room temperature. After three washes with
500 μL per well of 0.1% Tween-20 in PBS (PBS-T 0.1%),
membranes were immersed in solution of secondary
antibody, goat anti-human IgG immunoglobulin conju-
gated with peroxidase (Sigma-Aldrich Co., USA), diluted
1:1,000 or 1:2,000 in PBS-L 3%, for 90 minutes, at room
temperature. After incubation, membranes were washed
three times again. Then, membranes were immersed in a
fresh solution containing 15 mg of 4-chloro-1-naphtol
(Sigma-Aldrich Co., USA) diluted in 5 mL of absolute
methanol, 30 μL of 30-vol hydrogen peroxide and 20 mL
Tris-HCl 0,5 M pH 6.8. The reaction was stopped by
washing with distilled water. The NC squares were dried
on filter paper and the development of blue dots was
considered evidence of a positive result.
Analysis of the membrane stability
Nitrocellulose membranes previously sensitized with the
P. brasiliensis antigen, were maintained at –20 °C, 8 °C
and room temperature and evaluated progressively for
the antigenic reactivity over the time periods of 7, 15,
30, 45, 60 and 90 days, by DE with 11 serum samples
randomly chosen among the 300 samples with clinical
suspicion of PCM.
Three researchers with expertise in enzyme-linked
immunosorbent assays such as immunoblotting (IB) and
ELISA performed the analysis of anonymous serum
sample. Samples were sequentially numbered avoiding
identification of cases and controls by analysts. The DE
assays were then performed on different days, including
all the steps of the method. The test was carried out in
duplicate to evaluate the intra- and inter-assay according
to the content.
Double immunodifusion assay
Reactions were performed according to the modified
Ouchterlony’s method [25]. Glass slides were covered
with 3.0 mL of 1% agarose gel type II medium (Sigma
Chemical Co., USA) diluted in a buffered saline solution
pH 6.9 containing 0.4% sodium citrate and 7.5% glycine.
Antigen (12 μL) was placed in the central well, while
control and patient sera (12 μL) were added in sur-
rounding wells. The slides were incubated in a humid
chamber at room temperature for 48 hours. Then, they
were washed with saline solution with several changes
over a 24-hour period. Gels were dried and stained in
0.4% Coomassie brilliant blue R-250® (Sigma Chemical
Co., USA) in an ethanol-acetic acid-water mixture as
solvent.
Statistical analysis
The diagnostic accuracy of DE was evaluated by sensitiv-
ity (proportions of positive samples correctly identified
by the test) and co-sensitivity (considering DI as the
standard assay), specificity (proportions of negative sam-
ples correctly identified by the test) and co-specificity
(considering DI as the standard assay), predictive values
of Dot-ELISA test was determined and the main results
were calculated according to Jacobson [26]. The agree-
ment index of tests was calculated and classified by
Kappa coefficient according to Landis and Koch [27]. Fi-
nally, for proportion comparison we used the chi-square
test, performed by the Epi Info 6.1 program (Center for
Disease Control and Prevention - http:// www.cdc.gov)
with p ≤ 0.05 significance value.
Results
In order to standardize the Dot-ELISA assay, several
experiments were performed to define the optimal con-
ditions to improve this methodology. Conditions estab-
lished were:
 Employment of culture filtrate obtained from the B-
339 strain of P. brasiliensis instead of culture filtrate
obtained from Pb 113 isolate.
 The optimal concentration of the antigen tested on
the NC squares was 42 ng/μL.
 A dilution of 1:100 of sera from patients with
paracoccidioidomycosis, tuberculosis, histoplasmosis
or aspergilosis and healthy individuals.
 A dilution of 1:2000 of secondary antibody labelled
with peroxidase.
Positive reactions were visualized as spots varying
from dark purplish blue (strongly reactive sera) to pale
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purplish blue (weakly reactive sera), depending on the
intensity of the reaction. Results were considered nega-
tive when no color was observed (Fig. 1). The intrinsic
parameters were calculated for both methodologies (DE
and DI): sensitivity of 91% (70/77) and 72.7% (56/77),
specificity of 95.4% (63/66) and 98.5% (65/66), accuracy
of 93% and 84.6% (121/143), positive and negative
predictive values were 96% (70/73) and 98.2% (56/57),
90% (63/70) and 75.6% (65/86), respectively (Table 1).
The performances of DE compared to that of DI
standard method were evaluated using 300 samples from
patients with clinical suspicion (probable and possible
cases) of PCM. Anti-P. brasiliensis circulating antibodies
were detected in 34% of samples using DI, while DE had
detected these antibodies in 47.3% of samples. Discrim-
inatory capacity of both methods suggested that DE
assay has a tendency to increase the reactivity pattern, as
it was recognized by 40 more samples (13.3%) than DI.
Co-positivity (relative sensitivity) and co-negativity (rela-
tive specificity) values, using the DI assay as the standard
serological test, were 92% (101/110) and 99.5% (189/
190) respectively, achieving an agreement level between
them of κ = 0.93, considered very good.
The reproducibility of the test has shown that the
intra-observer and inter-observer were extremely satis-
factory, since their duplicates kept equal both in the
result itself (reactive, non-reactive or undetermined) and
in the staining intensity.
The evaluation of the viability of previously sensitized
nitrocellulose membranes with the B-339 antigen was
performed by DE probed against the 11 serum samples
from patients with PCM clinical suspicion (probable and
possible cases). Reactivity was observed on the mem-
branes up to 90 days.
Discussion
In Brazil, paracoccidioidomycosis has significant rates of
mortality that are estimated to be between 2 and 23% in
severe cases, and can reach up to 30% when associated
with AIDS [28]. In addition, it is considered the major
cause of mortality among mycoses in the country with
an average of 111.5 deaths/year [1, 6, 7], according to
the Mortality Information System (Brazilian Ministry of
Health). The clinical diagnosis of this mycosis can be
mistaken for others infectious diseases including those
caused by Leishmania spp. and Mycobacterium tubercu-
losis. Based on these factors, it becomes clear that the
establishment of an early and accurate diagnosis of PCM
is necessary for effective and specific initiation of ther-
apy. This measure will reduce the unnecessary use of
drugs and empiric therapy, thereby minimizing the
emergence of multidrug-resistant fungal strains.
Recently, there has been great interest in the imple-
mentation of fast inexpensive methodologies that could
also present high rates of sensitivity and specificity in
the immunodiagnosis of microbial and parasitic diseases.
In this sense, the dot-ELISA assay has been described as
an appropriate method for the detection of antibodies or
antigens in different human and animal infectious dis-
eases including paracoccidiodomycosis [16–19, 29, 30].
The pioneering study of Taborda and Camargo [17]
standardized the methodology for the detection of IgG
anti-gp43 antibodies, employing glycosylated and degly-
cosylated purified gp43, in the diagnosis and follow-up
of patients with PCM. The sensitivity and specificity of
this assay was 100% when gp43 was treated with sodium
metaperiodate. Martins et al. [18] using a mixture
composed by culture filtrate and somatic antigens of
P. brasiliensis yeast cells obtained 96.2% of sensitivity.
Correa et al. [19] using the 27 kDa recombinant anti-
gen obtained 100% of sensitivity and 98% of specifi-
city. More recently, Assunção [30] using recombinant
gp43 (gp43ΔNt) in PCM immunodiagnosis, observed
100% of sensibility and specificity after sodium meta-
periodate treatment.
Fig. 1 Reactivity pattern of Dot-ELISA assay: (a) positive reaction, (b) undetermined reaction and (c) non-reactive result
Table 1 Serological intrinsic parameters of double
immunodiffusion test (DI) and Dot-ELISA technique (DE)






PPV positive predicted value, NPV negative predicted value
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In the present study, employing culture filtrate
obtained from B-339 P. brasiliensis strain in DE assay,
we obtained 91% of sensitivity and 95.4% of specificity
against 72.7% of sensitivity and 98.5% of specificity in
DI. Statistical analysis, using chi-squared test, showed
that DE technique was significantly more sensitive (p =
0.000067) than DI method, proving and enhancing the
applicability of immunoenzymatic assays as optimal
methodologies for serological screening.
The small distinct sensitivity observed in this study
compared to other results – Taborda and Camargo [17],
Martins et al. [18], Correa et al. [19] and Assunção [30]
– might be related to differences in the standardization
of the methodology, to the nature of the employed anti-
gen, or due the fact that some samples presented no re-
action by the DI assay, which indicates that patients
were in clinical and/or serological cure. As stated by
Perenha-Vianna et al. [31] there is an important limita-
tion on antigenic preparations employed in serological
methodologies that must be overcome. P. brasiliensis
antigens are not commercially available and are usually
obtained via in-house productions in research centers.
Thus, the lack of standardization in protocols to obtain
P. brasiliensis antigens causes large differences on test
reproducibility.
Moreover, there is some evidence that support the use
of crude antigen as immunobiological for anti-P. brasi-
liensis circulating antibody research, instead of 43 kDa
purified molecule due to the following: (i) gp43 presents
several isoforms [32, 33]; (ii) P. brasiliensis expresses
variable amounts of gp43 [34]; and (iii) levels of gp43
may vary according to the isolate [35]. Therefore, an in-
dividual infected with an isolate that produces gp43 at
low rates will not present antibodies specific for this
antigen at detectable concentrations, which proves the
difficulty in using gp43 for the universal serological diag-
nosis of PCM [36].
Thus, the present study showed similar intrinsic par-
ameter values of DE assay, using culture filtrate
obtained from the B-339 strain of P. brasiliensis, when
compared to those previously standardized, because it
employed more specific and refined antigenic prepara-
tions. This finding has major advantages for public
health laboratories, since obtaining the culture filtrate
is significantly less costly and requires less complex
procedures than those required to obtain purified and/
or recombinant antigens. Another point that deserves
special attention is the good performance (in liters) and
the excellent stability of the culture filtrate, more than
15 years after production [37]. Furthermore, we found
that the use of culture filtrate also provides good index
of sensitivity, specificity, accuracy, positive and negative
predictive values, secured the intermediate repeatability
and reproducibility of the Dot-ELISA assay.
In recent years, medical laboratories have undergone
intense changes, especially regarding quality assurance
of products offered. Hawkins [38] highlighted the signifi-
cant number of publications that link the laboratory fail-
ures, estimated at 7-13%, to the possibility of these
occurring in the analytical phase. In the validation
process, DE methodology was evaluated against 300
convenience samples, i.e. samples from individuals with
clinical suspicion (probable and possible cases) of para-
coccidioidomycosis. It was found that the relative sensi-
tivity and relative specificity values, using the DI assay as
the standard serological test, were 92% and 99.5%,
respectively, which achieved an agreement level between
them of κ = 0.93, considered great. In the present study,
we also verified coherence in the interpretation of results
between observers (intra and inter-observer). Compari-
son of DE methodology with different serologic assays
has been thoroughly carried out by other authors [16,
39, 40]. It is unanimous that DE reaction is an excellent
tool, primarily for seroepidemiological investigations,
that is extremely adaptable in extra-laboratory settings
and allows the evaluation of a high number of samples
while using smaller amounts of antigen. Another
important finding in this study relates to stability of
nitrocellulose membranes endowed with the culture
filtrate of P. brasiliensis.
Despite the good results obtained with membranes
that were not blocked and stored at –20 °C, the best re-
sults were observed with membranes stored at room
temperature up to 90 days (not blocked). Future studies
should be conducted to assess the stability for longer
periods. However, this finding opens the possibility of
sending sensitized membranes to distant laboratories,
enabling the realization of seroepidemiological surveys
in settlements of people involved with rural activities or
living in endemic areas. Historically, DI assay has been
the technique of choice in the diagnosis of PCM, immu-
noenzymatic reactions such as ELISA and IB have also
been used for the anti-P. brasiliensis antibodies detection
[3, 10, 12, 22, 31, 41, 42]. However, despite showing
good sensitivity the latter two have low specificity, and
often require the previous adsorption of serum samples
from patients with paracoccidioidomycosis with Histo-
plasma capsulatum or Candida albicans, dilution of
serum in galactose or sodium metaperiodate antigen
(gp43) treatment [43–45].
The Dot-ELISA proved to be extremely promising,
versatile and can be applied as a serological screening
test. Because of its high sensitivity as a methodology for
the early diagnosis of the disease, it allows the release of
negative results in less time than DI assay, i.e. one to
seven days, which is of great diagnostic value, especially
for the disposal of clinical suspicion of paracoccidioido-
mycosis. In addition, Dot-ELISA assay is less expensive
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than ELISA and IB, reagent conservative and does not
require electrically powered instruments to give sensitive
results. Its portability is ideal for use in field studies where
the majority of immunodiagnostic assays are limited by
their dependence on electricity, refrigeration or laboratory-
grade water.
Conclusions
Given the numerous advantages of the presented
methodology, this work proposes a broad discussion on
the current algorithm recommended by the Epidemio-
logical Surveillance Guide for Paracoccidioidomycosis of
São Paulo State, proposing the replacement of indirect
ELISA – currently recommended for the screening of
serum samples – for Dot-ELISA.
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